Kazazian Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,450
| Closed | -$84K | – | 48 |
|
|
2025
Q1 | $84K | Buy |
+10,450
| New | +$84K | 0.07% | 53 |
|
|
2019
Q3 | $446K | Hold |
83,572
| – | – | 0.6% | 35 |
|
|
2019
Q2 | $550K | Sell |
83,572
-13,484
| -14% | -$88.7K | 0.65% | 33 |
|
|
2019
Q1 | $631K | Sell |
97,056
-20,000
| -17% | -$130K | 0.88% | 28 |
|
|
2018
Q4 | $798K | Sell |
117,056
-53,300
| -31% | -$363K | 1.08% | 25 |
|
|
2018
Q3 | $1.13M | Hold |
170,356
| – | – | 1.06% | 24 |
|
|
2018
Q2 | $959K | Buy |
170,356
+14,230
| +9% | +$80.1K | 0.88% | 28 |
|
|
2018
Q1 | $810K | Hold |
156,126
| – | – | 0.85% | 30 |
|
|
2017
Q4 | $707K | Buy |
156,126
+16,189
| +12% | +$73.3K | 0.72% | 33 |
|
|
2017
Q3 | $877K | Buy |
139,937
+73,633
| +111% | +$461K | 1.07% | 22 |
|
|
2017
Q2 | $406K | Buy |
66,304
+21,304
| +47% | +$130K | 0.61% | 32 |
|
|
2017
Q1 | $330K | Buy |
+45,000
| New | +$330K | 0.46% | 29 |
|